- Table View
- List View
Multiple Sclerosis: Clinician's Guide to Diagnosis and Treatment (Oxford American Neurology Library)
by Gary L. BirnbaumMultiple Sclerosis (MS) is an inflammatory, often progressive, and potentially disabling disease of the central nervous system. Onset of disease is usually between the ages of 15 and 50, with the incidence nearly twice as high in women. While the cause of MS is still unknown, the predominant theory is that it is an autoimmune disease, triggered by an unknown environmental factor that results in both loss of central nervous system myelin and degeneration of axons and neurons. Although there have been a number of publications addressing different aspects of MS treatment in the neurological literature, there is a dearth of material on MS designed for internists and primary care physicians, who are often the first to see patients presenting with symptoms of MS. Therefore, this concise, clinically focused volume will serve as a valuable resource tailored to the specific needs of internists and primary care physicians. Part of the Oxford Neurology Library, this highly practical pocketbook covers current approaches and new developments in the diagnosis, treatment and management of MS, including both early and advanced stages of the disease. The book offers in-depth coverage of special populations, as well as the more unusual manifestations of MS, which are less familiar to the internal medicine audience. It will also address the role of imaging studies in the diagnosis, differential diagnosis and monitoring of the progression of MS. In addition to providing up-to-date information on pharmacological therapies for MS, the book also describes an array of non-pharmacological treatment options.
Multiple Sclerosis: Approaches to Management (Therapy in Practice Series #18)
by Lorraine De Souza Action and Research for Multiple Sclerosis
Multiple Sclerosis: A Critical Conspectus
by E. J. FieldAlthough a strikingly modem account of multiple (disseminated) sclerosis was given by Charcot more than one hundred years ago, we are still not sure of the precise nature of the disease, still less of any precise mode of management. Even diagnosis is at best 'probable'. This collection of essays examines the particular difficulties which beset the problem and have mili tated against the solution-problems of data collection and evaluation; clinical and biochemical vagaries and unanswered questions ; laboratory test prediction of the disease, etc. Experts in their fields have set out the difficulties and way forward as ther see them, and there must necessarily be overlap or contradictions which underline our lack of knowledge. Clearly no attempt can be made to cover more than a very few aspects of the problem (a further volume is planned to review other areas not covered here, in particular the relationship between multiple sclerosis and experimental allergic encephalo myelitis)-but it is hoped that the 'softness' of much of the data we have to work upon will become appan!~nt. It is intended that this volume should clearly differ from the large number of monographs and reports of symposia dedicated to multiple sclerosis in bringing out the shortcomings of our approaches, and in some respects our naivities rather than our individual brilliancies.
Multiple Sclerosis (Biographies of Disease)
by Lisa I. IezzoniWritten for students interested in learning about multiple sclerosis, this book describes how this frequently disabling disease affects patients, exploring its effects on minds, bodies, and daily lives.Written by a professor of medicine who is also personally affected by the disease, Multiple Sclerosis offers an overview of every aspect of the condition. It begins by introducing the central nervous system and describing how multiple sclerosis affects the brain and spinal cord. The author then reviews early understanding of MS, how it was first recognized as a disease, and the discoveries that have helped explain its causes. Moving to contemporary understanding of multiple sclerosis, the book explores the epidemiology of MS in the United States and around the world, describes MS symptoms, and reviews today's treatments and research directions. Perhaps most important, it presents the experiences of persons living with multiple sclerosis, concluding with a discussion of factors affecting these individuals in their homes, families, and communities.
Multiple Sclerosis: Etiology, Diagnosis, and New Treatment Strategies (Current Clinical Neurology)
by Michael OlekA synthesis of current concepts about the evaluation, treatment, and future directions in MS. On the evaluation side, the authors review the use of MRI, magnetic resonance spectroscopy, functional MRI, and three-dimensional MRI, and consider the rapidly developing body of pathologic information they have yielded. On the treatment side, the focus is on recently approved medications (Novantrone), new indications for medications (CHAMPS Trial), medications in development (Oral Interferon Tau, Oral Copaxone, and Oral Cellcept), immunosuppressive therapy for both progressive disease and symptomatic therapy; the current medications for treating relapsing-remitting MS (Avonex, Betaseron, and Copaxone) are also discussed. For future directions, the authors present the current best thinking, as well as the latest discoveries in immunology relating to MS, including groundbreaking B-cell research and its applications to specific immunotherapies, and the use of immune markers for tracking the disease.
Multiple Sclerosis: An Analysis of 812 Cases by Means of Electronic Data Processing (Schriftenreihe Neurologie Neurology Series #20)
by Sigrid PoserThe value of prospective long-term studies on the features and course of multiple sclerosis is determined by the reliability with which relevant infor mation is documented. This involves two basic problems: I) The docu mentation system used must be detailed enough to provide adequate data on the essential features and course of the disease in a given case; on the other hand, it must not be so complicated and cumbersome as to preclude its use in the routine care of MS patients. 2) Since no system can fully anticipate new problems and scientific approaches that may become impor tant at some future time, the system must be open to provide the possi bility of adding and correlating the data of special research studies with the . basic data. These considerations led to the development of the basic documentation system described here and employed for the analysis of clinical data in this monograph. The work was carried out with the help of the Deutsche Forschungsgemeinscha/t as a part of its research program on multiple sclerosis and related demyelinating disease. A basic documentation pool including the data of more than 2 000 patients has been accumulated in the last six years. The system has been put to practical use in a number of epidemiologic surveys completed or under way, in following up the cases in an epidemiologic observation area in South Lower Saxony, and in studies on spasticity, cerebrospinal fluid findings, clinical forms and neuro physiological aspects of MS.
Multiple Sclerosis
by Ian RobinsonMultiple Sclerosis affects hopes and expectations, restructures relationships, modifies careers and changes lives. It is a disease of variable onset, problematic diagnosis, unpredicatable prognosis and no effective treatment. Using unique autobiographical accounts of people with the disease, Ian Robinson sensitively portrays the difficulties and frustrations of the struggle to make sense of the clinical diagnosis and management of an illness which is effectively a way of life.
Multiple Sclerosis: Practical Advice To Help You Manage Your Multiple Sclerosis
by Ian RobinsonMultiple Sclerosis affects hopes and expectations, restructures relationships, modifies careers and changes lives. It is a disease of variable onset, problematic diagnosis, unpredicatable prognosis and no effective treatment. Using unique autobiographical accounts of people with the disease, Ian Robinson sensitively portrays the difficulties and frustrations of the struggle to make sense of the clinical diagnosis and management of an illness which is effectively a way of life.
Multiple Sclerosis (Contemporary Neurology Series)
by Moses Rodriguez Orhun H. Kantarci Istvan PirkoThis latest edition to the 'Contemporary Neurology Series' will fill one of the few remaining 'neurologic gaps' within the Series. 'Multiple Sclerosis,' written solely by Moses Rodriguez, Orhun Kantarci and Istvan Pirko of the Mayo Clinic in Rochester, MN will offer proven, effective treatments for specific presentations and symptoms of multiple sclerosis along with a pathophysiological explanation of why they work. It bridges a needed gap between overly simplistic therapy manuals and basic science texts that discuss human disease only insofar as it mimics what is observed in animal models of the disease in the laboratory. Additionally, it seeks to offer an efficient integrative approach to symptomatic treatment to avoid over-medication and side effects. It discusses the heterogeneous causes of the disease and the need to develop individualized treatments that address the basic pathophysiologic processes that characterize each patient's disease with the future goal of individualized medicine. 'Multiple Sclerosis' covers both the basic research aspects of MS: epidemiology, neuropathology, genetics, and immunology as well as the treatment options associated with the MS patient: sleep, steroids, pharma, neuropsychology, and growth factors (to name a few). 'Multiple Sclerosis' will focus on the medical treatment - drug treatment - of MS rather than on physical medicine and rehabilitation (not the author's strength). The authors will also make ample use of flow diagrams, bulleted points, and tables to help the reader better understand MS and its etiology and treatment.
Multiple Sclerosis: Advances in Clinical Trial Design, Treatment and Future Perspectives (Clinical Medicine And The Nervous System Ser.)
by Richard A. Rudick Donald E. GoodkinThis book reviews the therapeutic developments in clinical trial design that have resulted in new treatment options for patients suffering from MS. Important ethical considerations that arise with the new treatments are included, as well as the perspective on the emergence of MS as a treatable disease.
Multiple Sclerosis
by Richard ThomasThis still incurable disease of the nervous system leads to major disability and paralysis. The fatigue, depression and pain MS causes makes it particularly hard for sufferers and their families to cope with. An explanation of MS Possible causes and triggers Diet, exercise and relaxation techniques
Multiple Sclerosis: Diagnosis and Therapy (Perspectives Cshl Ser.)
by Howard L. Weiner James M. StankiewiczMultiple Sclerosis: a complex disease requiring sophisticated management Multiple Sclerosis poses labyrinthine challenges. There is no blood test to rely on for diagnosis; clinical acumen is essential. Yet an effective diagnosis only takes you part of the way: treatment offers further enigmas. The MS treatment landscape is complicated, and will become even more so with time. Multiple Sclerosis: Diagnosis and Therapy is the map you need to navigate this maze. Written and edited by leaders in the field, it guides you towards effective and positive choices for your patients. The diagnosis section provides state-of-the-art thinking about pathogenesis. With clear coverage of biomarkers, genetics, and imaging, it presents a coherent framework for making the correct diagnosis. The management section comprehensively covers current and future treatments to steer you through the many options for • Symptom management • Cognitive dysfunction • Depression and other mental health issues ‘Top Tips’ throughout provide the practical guidance you need for the best management of your patients. Multiple Sclerosis: Diagnosis and Therapy should be on the bookshelf of anyone who treats patients with multiple sclerosis.
Multiple Sclerosis: Diagnosis and Therapy
by Howard L. Weiner James M. StankiewiczMultiple Sclerosis: a complex disease requiring sophisticated management Multiple Sclerosis poses labyrinthine challenges. There is no blood test to rely on for diagnosis; clinical acumen is essential. Yet an effective diagnosis only takes you part of the way: treatment offers further enigmas. The MS treatment landscape is complicated, and will become even more so with time. Multiple Sclerosis: Diagnosis and Therapy is the map you need to navigate this maze. Written and edited by leaders in the field, it guides you towards effective and positive choices for your patients. The diagnosis section provides state-of-the-art thinking about pathogenesis. With clear coverage of biomarkers, genetics, and imaging, it presents a coherent framework for making the correct diagnosis. The management section comprehensively covers current and future treatments to steer you through the many options for • Symptom management • Cognitive dysfunction • Depression and other mental health issues ‘Top Tips’ throughout provide the practical guidance you need for the best management of your patients. Multiple Sclerosis: Diagnosis and Therapy should be on the bookshelf of anyone who treats patients with multiple sclerosis.
Multiple Sclerosis: Methods and Protocols (Methods in Molecular Biology #1304)
by Robert WeissertThis detailed volume covers molecular biology, cellular biology, biomarkers, imaging, and neuropathological methods and techniques to explore multiple sclerosis (MS), with a special emphasis on disease models. With so much effort needed to elucidate basic disease mechanisms, to clone disease relevant genes, to define novel biomarkers, and to discover novel and improved therapeutic and curative treatments, this book serves to aid researchers in accomplishing these enormous goals. Written for the highly successful Methods in Molecular Biology series, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls.Practical and easy to use, Multiple Sclerosis: Methods and Protocols will empower the reader to perform novel research regarding pathophysiology and treatment for MS.
Multiple Sclerosis 3, Volume 34 E-Book: Blue Books of Neurology Series
by Claudia Lucchinetti Reinhard HohlfeldMultiple Sclerosis 3 emphasizes the latest in the pharmacologic treatment of this incurable inflammatory demyelinating disorder. Primary editors Claudia Lucchinetti, MD, and Reinhard Hohlfeld, MD, with the aid of all new contributors, present a complete and current reference on multiple sclerosis that includes discussions of such hot topics as Biomarkers, Genomics, and Surrogate Outcomes in MS; Pediatric MS; Transverse Myelitis; Attack Therapies in MS; Current Disease-Modifying Therapeutic Strategies in MS; Management of Aggressive MS; Symptomatic Therapies in MS; Complementary and Alternative Medical Therapies; and Strategies to Promote Neuroprotection and Repair. Distinguish between MS and other similar demyelinating disorders and know the best and most aggressive methods of treatment. This title in the Blue Books of Neurology series is exactly what you need to treat the disease and its relapses.Covers the latest clinical advances and relevant discussions—Biomarkers, Genomics, and Surrogate Outcomes in MS; Pediatric MS; Transverse Myelitis; Attack Therapies in MS; Current Disease-Modifying Therapeutic Strategies in MS; Management of Aggressive MS; Symptomatic Therapies in MS; Complementary and Alternative Medical Therapies; and Strategies to Promote Neuroprotection and Repair—to bring you up to date and keep your practice state-of-the-art. Features a greater emphasis on practical management to help you determine the type of multiple sclerosis and the best course of therapy. Focuses on pharmaceutical therapies so you know the best and most aggressive methods and which drugs to use for treatment. Includes extensive information on differential diagnosis so that you can clearly distinguish between multiple sclerosis and other similar demyelinating disorders. Presents expert new editors and experienced contributing authors for the most current and relevant practice information. Emphasizes the pharmacologic management of patients with multiple sclerosis to address treating the actual disease and its relapses as well as treating the symptoms.
Multiple Sclerosis and CNS Inflammatory Disorders (NIP- Neurology in Practice)
by Lawrence M. Samkoff Andrew D. GoodmanMultiple Sclerosis and CNS Inflammatory Disorders is a practical guide to effective care of patients with multiple sclerosis and other neuroimmunologic and CNS inflammatory disorders. It provides the scientific basis of multiple sclerosis including etiology, epidemiology, and pathogenesis. It covers the diagnostic process, the course of the disease and prognosis, and the use of MRI in diagnosis and disease monitoring. Disease-modifying treatment algorithms for relapsing-remitting multiple sclerosis, switching therapy, and progressive multiple sclerosis treatment algorithms are all discussed in detail. It also addresses multiple sclerosis in childhood and pregnancy and includes assessment of alternative therapies. This new addition to the Neurology in Practice series contains practical guidance and learning features: • Algorithms and guidelines • “Tips and Tricks” boxes on improving outcomes • “Caution” warning boxes to avoiding problems • “Science Revisited”—quick reminders of the basic science principles necessary for understanding Multiple Sclerosis and CNS Inflammatory Disorders is an ideal reference for neurologists in practice and training.
Multiple Sclerosis and CNS Inflammatory Disorders (NIP- Neurology in Practice)
by Lawrence M. Samkoff Andrew D. GoodmanMultiple Sclerosis and CNS Inflammatory Disorders is a practical guide to effective care of patients with multiple sclerosis and other neuroimmunologic and CNS inflammatory disorders. It provides the scientific basis of multiple sclerosis including etiology, epidemiology, and pathogenesis. It covers the diagnostic process, the course of the disease and prognosis, and the use of MRI in diagnosis and disease monitoring. Disease-modifying treatment algorithms for relapsing-remitting multiple sclerosis, switching therapy, and progressive multiple sclerosis treatment algorithms are all discussed in detail. It also addresses multiple sclerosis in childhood and pregnancy and includes assessment of alternative therapies. This new addition to the Neurology in Practice series contains practical guidance and learning features: • Algorithms and guidelines • “Tips and Tricks” boxes on improving outcomes • “Caution” warning boxes to avoiding problems • “Science Revisited”—quick reminders of the basic science principles necessary for understanding Multiple Sclerosis and CNS Inflammatory Disorders is an ideal reference for neurologists in practice and training.
Multiple Sclerosis and Related Disorders (Handbook of Clinical Neurology #Volume 122)
by Douglas S. GoodinMultiple Sclerosis (MS) is generally understood to be an inflammatory autoimmune disease of the central nervous system. While we still are not certain of the root cause of MS, research results suggest that unknown environmental factors and the presence of specific genes seem the most probable targets. MS causes an inflammatory response in the central nervous system leading to neurodegeneration, oligodendrocyte death, axonal damage, and gliosis. Over the past five years ongoing research has greatly expanded our understanding of the pathogenesis of MS, detailed insight into the epidemiology and genetic factors related to MS, the introduction of new technologies and tests to better diagnose and predict the future course of the disease and the introduction of new treatments targeting MS. This collection of review chapters provides a comprehensive reference into the science and clinical applications of the latest Multiple Sclerosis research and will be a valuable resource for the neuroscience research community and the clinical neurology community of researchers and practitioners. - A comprehensive tutorial reference detailing our current foundational understanding of Multiple Sclerosis - Includes chapters on key topics including the genetics of MS, MRI imaging and MS, and the latest treatment options - Each chapter is translational and focuses on current research and impact on diagnosis and treatment options
The Multiple Sclerosis Companion: Answers to the most frequently asked questions from people with MS
by Anke FriedrichThe book provides competent assistance to all those affected by Multiple Sclerosis to better understand the disease and educates them about current diagnostic methods and treatment approaches. With independent information, the guidebook provides the key to a self-determined life with the disease. Complex medical facts such as the malfunctioning immune system or MRI findings are explained in understandable words and accompanying drawings. This companion also raises awareness beyond conventional medicine to take into account important influencing environmental factors.The author provides answers to the many questions that are asked again and again in the doctors’ practices and cannot always be answered to this extent and with this clarity due to time restrictions. For this reason, it is a highly helpful tool to both MS practitioner and patient.The book is structured as follows:What is MS? - How the central nervous system is structured - What happens when the nervous system is misdirected - MS relapse and typical symptoms - The path to diagnosis - An excursion into our immune system - The MRI findings - Why lumbar puncture - What to do during an MS relapse - I'm fine, why therapy? - MS and the desire to have children - What can I do myself: Nutrition, Vitamin D, intestine and microbiome.
Multiple Sclerosis Immunology: A Foundation for Current and Future Treatments
by Takashi Yamamura and Bruno GranThe availability of powerful genome-wide association study technology, during the last five years, has shown that most of the “new” MS susceptibility loci are immune-response genes. It is clear that there is much novelty in the field of MS immunology, which has served as an impetus to invest in new therapies. Notably, most if not all of these are immunotherapies. Even the equally exciting field of cell-based therapies and neuro-regeneration may well rely on cells or growth factors that are no less immunomodulators than restorative of myelin and neural cell function. Multiple Sclerosis Immunology looks at MS immunology as the basis for the present and—even more—the future of treatments for this complex autoimmune condition. Both editors are immunologists, as well as clinical neurologists, and appreciate the importance of a sustained dialogue between basic and clinical scientists to ensure that “translation” is real and not just virtual.
Multiple Sclerosis, Mad Cow Disease and Acinetobacter
by Alan EbringerThe aim of this book is to publicise and bring to a wider audience the concept that the cause of two neurological diseases, namely multiple sclerosis (MS) and “mad cow disease” also known as “bovine spongiform encephalopathy” are related through exposure to a common microbe Acinetobacter which is found in human sinuses, on skin and in the soil. An infection is the cause of a neurological disease in man and in animals. Elevated levels of antibodies to Acinetobacter have been found in multiple sclerosis patients as well as in ruminants who have been described as suffering from “mad cow disease” following exposure to contaminated feed supplements. The overall objective and scope of this book is to inform the audience, the reader, that multiple sclerosis may be linked to a microbe Acinetobacter which carries molecular structures resembling myelin, the outer sheath covering of neurons.
Multiple Sclerosis Rehabilitation: From Impairment to Participation
by Marcia Finlayson"MS is always in the back of your mind. If there is something you want to do, you always wonder if the MS will allow you do to it."-Darlene, living with MS for 22 yearsLiving with multiple sclerosis (MS) is challenging and multidimensional. MS pervades all aspects of life: one's body becomes unpredictable and unreliable, one's identity and sense of
Multiple Sclerosis Research in Europe: Report of a Conference on Multiple Sclerosis Research in Europe, January 29th–31st 1985, Nijmegen, The Netherlands. Sponsored by the Commission of the European Communities, as advised by the Committee on Medical Public Health Research
by Otto R. HommesMultiple sclerosis is an unique disease with a tremendous impact on social life in countries with moderate climates. Its cause is unknown. In recent years however hopes have been raised that the disease might be fought, and possibly cured. With the disappearance of poliomyelitis as the main paralyzing disease multiple sclerosis has taken its place as the single disease that is responsible for paralyzing the young with an incurable affliction of long duration, for social disruption and for an 1 economic impact that is estimated to be higher than heart disease • A multi-national, mUlti-disciplinary approach to this extremely disabling disease is urgently needed in this phase of hopeful scientific developments. The Commission of the European Communities therefore sponsored a Con ference on Multiple Sclerosis Research in Europe on 29,30 and 31 January 1985 in Nijmegen, The Netherlands, with the aim of formulating practical proposals for such cooperation in the Communities. This volume contains the papers read at that conference.